BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9566020)

  • 1. Esculentoside A inhibits tumor necrosis factor, interleukin-1, and interleukin-6 production induced by lipopolysaccharide in mice.
    Ju DW; Zheng QY; Cao X; Fang J; Wang HB
    Pharmacology; 1998 Apr; 56(4):187-95. PubMed ID: 9566020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esculentoside A suppresses lipopolysaccharide-induced pro-inflammatory molecule production partially by casein kinase 2.
    Li Y; Cao Y; Xu J; Qiu L; Xu W; Li J; Song Y; Lu B; Hu Z; Zhang J
    J Ethnopharmacol; 2017 Feb; 198():15-23. PubMed ID: 28027904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibitory effects of esculentoside A on mouse macrophages and antibody production].
    Ju DW; Zheng QY; Wang HB; Guan XJ; Fang J; Yi YH
    Yao Xue Xue Bao; 1994; 29(4):252-5. PubMed ID: 7976339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esculentoside A inhibits LPS-induced acute kidney injury by activating PPAR-γ.
    Chen DZ; Chen LQ; Lin MX; Gong YQ; Ying BY; Wei DZ
    Microb Pathog; 2017 Sep; 110():208-213. PubMed ID: 28666844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of esculentoside H on release of tumor necrosis factor from mouse peritoneal macrophages.
    Hu ZL; Zhang JP; Yi YH; Qian DH
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):550-2. PubMed ID: 8010057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of esculentoside A on production of interleukin-1, 2, and prostaglandin E2.
    Xiao ZY; Zheng QY; Jiang YY; Zhou B; Yin M; Wang HB; Zhang JP
    Acta Pharmacol Sin; 2004 Jun; 25(6):817-21. PubMed ID: 15169638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of esculentoside A on lipopolysaccharide-induced acute lung injury in mice.
    Zhong WT; Jiang LX; Wei JY; Qiao AN; Wei MM; Soromou LW; Xie XX; Zhou X; Ci XX; Wang DC
    J Surg Res; 2013 Nov; 185(1):364-72. PubMed ID: 23764313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory effect of esculentoside A on platelet activating factor released from calcimycin induced rat peritoneal macrophages].
    Fang J; Zheng QY
    Yao Xue Xue Bao; 1991; 26(10):721-4. PubMed ID: 1823713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
    Rim HK; Cho W; Sung SH; Lee KT
    J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esculentoside A specifically binds to ribosomal protein S3a and impairs LPS-induced signaling in macrophages.
    Li YH; Wang J; Liu Y; Qiu L; Li JZ; Hu HG; Hu ZL; Zhang W; Lu B; Zhang JP
    Int Immunopharmacol; 2018 Jan; 54():254-260. PubMed ID: 29169044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esculentoside A inhibits LPS-induced BV2 microglia activation through activating PPAR-γ.
    Li-Hua D; Yan L; Shi-Ji W; Guang W; Lu-Lu S; Xue-Feng P; Pengda S
    Eur J Pharmacol; 2017 Oct; 813():61-65. PubMed ID: 28733218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective effect of Esculentoside A on experimental acute liver injury in mice.
    Zhang F; Wang X; Qiu X; Wang J; Fang H; Wang Z; Sun Y; Xia Z
    PLoS One; 2014; 9(11):e113107. PubMed ID: 25405982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kalopanaxsaponin B inhibits LPS-induced inflammation by inhibiting IRAK1 Kinase.
    Joh EH; Jeong JJ; Kim DH
    Cell Immunol; 2012 Sep; 279(1):103-8. PubMed ID: 23117333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chikusetsusaponin IVa Methyl Ester Isolated from the Roots of Achyranthes japonica Suppresses LPS-Induced iNOS, TNF-α, IL-6, and IL-1β Expression by NF-κB and AP-1 Inactivation.
    Lee HJ; Shin JS; Lee WS; Shim HY; Park JM; Jang DS; Lee KT
    Biol Pharm Bull; 2016; 39(5):657-64. PubMed ID: 27150139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of tumor necrosis factor and subsequent endotoxin shock by pirfenidone.
    Cain WC; Stuart RW; Lefkowitz DL; Starnes JD; Margolin S; Lefkowitz SS
    Int J Immunopharmacol; 1998 Dec; 20(12):685-95. PubMed ID: 9877280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral IL-10 gene therapy inhibits TNF-alpha and IL-1 beta, not IL-6, in the newborn endotoxemic mouse.
    Drazan KE; Wu L; Bullington D; Shaked A
    J Pediatr Surg; 1996 Mar; 31(3):411-4. PubMed ID: 8708914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo inhibition of endotoxin-induced pro-inflammatory cytokines production by the sigma ligand SR 31747.
    Derocq JM; Bourrié B; Ségui M; Le Fur G; Casellas P
    J Pharmacol Exp Ther; 1995 Jan; 272(1):224-30. PubMed ID: 7815336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo therapeutics of β-thujaplicin on LPS-induced inflammation in macrophages and septic shock in mice.
    Shih MF; Chen LY; Tsai PJ; Cherng JY
    Int J Immunopathol Pharmacol; 2012; 25(1):39-48. PubMed ID: 22507316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of several mediators of inflammation on the mouse hypothalamo-pituitary-adrenal axis response during acute endotoxemia.
    Hadid R; Spinedi E; Chautard T; Giacomini M; Gaillard RC
    Neuroimmunomodulation; 1999; 6(5):336-43. PubMed ID: 10474052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of post-treatment with low-dose propofol on inflammatory responses to lipopolysaccharide-induced shock in conscious rats.
    Hsu BG; Yang FL; Lee RP; Peng TC; Chen HI
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):24-9. PubMed ID: 15730430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.